#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12852	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2096	607.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	708	C,G	690,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12852	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2096	607.4	0	HET	.	.	.	C451T,G	.	451	451	C	696	696	C	746	C,T,G	538,186,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23360	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3490	664.5	0	.	n	.	0	T695C	SNP	695	695	T	953	953	C	719	C	708	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23360	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3490	664.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2229	2229	C	710	C	691	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23360	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3490	664.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2303	2303	A	780	A	765	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23360	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3490	664.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2855	2855	C	748	C	729	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1590	folP	855	855	100.0	folP.l15.c4.ctg.1	1587	99.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1127	1129	AGC	161;161;163	A;G,T;C	156;155,1;156	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4310	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3297	129.7	1	SNP	p	S91F	1	.	.	271	273	TTC	555	557	TTC	140;139;140	T;T;C	137;136;134	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4310	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3297	129.7	1	SNP	p	D95G	1	.	.	283	285	GGC	567	569	GGC	132;133;132	G;G;C	129;131;128	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4310	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3297	129.7	1	SNP	p	G95N	0	.	.	283	285	GGC	567	569	GGC	132;133;132	G;G;C	129;131;128	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1438	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1399	102.3	1	SNP	p	G45D	0	.	.	133	135	GGC	565	567	GGC	200;197;197	G;G;C	195;193;192	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	732	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	996	73.1	0	.	n	.	0	A197.	DEL	197	197	A	611	611	A	165	A	163	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4360	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2866	150.8	1	SNP	p	D86N	0	.	.	256	258	GAC	572	574	GAC	143;143;144	G;A;C	139;138;143	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4360	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2866	150.8	1	SNP	p	R87I	0	.	.	259	261	CGT	575	577	CGT	142;143;143	C;G;T	141;137;135	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4360	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2866	150.8	1	SNP	p	S87R	1	.	.	259	261	CGT	575	577	CGT	142;143;143	C;G;T	141;137;135	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4360	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2866	150.8	1	SNP	p	R87W	0	.	.	259	261	CGT	575	577	CGT	142;143;143	C;G;T	141;137;135	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4360	parC	2304	2304	100.0	parC.l6.c17.ctg.1	2866	150.8	1	SNP	p	S88P	0	.	.	262	264	TCC	578	580	TCC	141;140;141	T;C;C	136;137;138	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3308	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2654	123.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	184;184;183	G;G;C	178;177;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1278	1280	GCC	188;188;191	G;C;C	181;182;184	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1281	1283	ATG	194;194;196	A;T;G	188;189;189	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1293	1295	ACC	193;192;192	A;C;C	184;188;185	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1293	1295	ACC	193;192;192	A;C;C	184;188;185	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1794	1796	ACC	178;177;176	A;C;C,A	168;171;167,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1848	1850	GCG	166;165;165	G;C;G	160;158;158	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1848	1850	GCG	166;165;165	G;C;G	160;158;158	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1971	1973	GGT	132;132;132	G;G;T	122;124;123	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1980	1982	AGC	129;129;129	A;G;C	120;119;118	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3402	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2351	143.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1998	2000	CCG	100;101;99	C,G;C;G,T	94,2;94;86,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4800	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3109	153.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1683	1685	CCG	198;197;197	C;C;G,C	178;185;177,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2310	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1868	122.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	540	540	C	154	C	146	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2444	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1276	182.9	1	SNP	p	G120K	1	.	.	358	360	AAG	478	480	AAG	184;188;190	A,G;A,G;G,T	175,1;183,1;178,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2444	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1276	182.9	1	SNP	p	A121N	1	.	.	361	363	AAC	481	483	AAC	190;191;193	A,G;A,C;C	183,1;186,1;181	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2444	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1276	182.9	1	SNP	p	N121D	0	.	.	361	363	AAC	481	483	AAC	190;191;193	A,G;A,C;C	183,1;186,1;181	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8710	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4699	184.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1076	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1080	98.7	1	SNP	p	V57M	1	.	.	169	171	ATG	579	581	ATG	200;200;202	A;T;G	193;190;195	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
